Literature DB >> 3489354

Blood lymphocyte subsets in patients with primary intracranial tumours. Correlation to histological tumour type and anatomical site.

H Ullén, U Blom, H Blomgren, H von Holst.   

Abstract

The blood lymphocyte population of 118 patients with primary intracranial tumours and healthy volunteers was examined with respect to its size and cellular composition using various rosette tests. The patients had not undergone any surgical intervention or received any treatment with ionizing irradiation or cytotoxic drugs. However, some of them were treated with corticosteroids. It was observed that non-steroid treated patients with oligodendrogliomas, but not patients with other histological types of tumours, had a significantly reduced proportion of "active" T-lymphocytes forming rosettes with sheep erythrocytes (a type of T-lymphocyte which is activated by foetal calf serum). These patients as well as those with astrocytomas, malignant gliomas (anaplastic astrocytomas and glioblastomas) or miscellaneous tumours (mainly meningiomas) had normal proportions of lymphocytes with receptors for the Fc-part of IgG or C'3 and cells forming rosettes with sheep erythrocytes under more conventional conditions. Patients who were treated with corticosteroids had an increased frequency of lymphocytes with the above Fc-receptor. An association between site of the lesions and cellular composition of the blood lymphocyte population was not detected. The results give further support for the view that the immunological system may be changed in patients with oligodendrogliomas.

Entities:  

Mesh:

Year:  1986        PMID: 3489354     DOI: 10.1007/BF01401229

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  22 in total

1.  Steroid sensitivity of the response of human lymphocytes to phytohemagglutinin and pokeweed mitogen: role of phagocytic cells.

Authors:  H Blomgren
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors.

Authors:  W H Brooks; T L Roszman; A S Rogers
Journal:  Cancer       Date:  1976-04       Impact factor: 6.860

4.  A monoclonal antibody against human T suppressor lymphocytes binds specifically to the surface of cultured oligodendrocytes.

Authors:  J Oger; S Szuchet; J Antel; B G Arnason
Journal:  Nature       Date:  1982-01-07       Impact factor: 49.962

5.  Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.

Authors:  M S Mahaley; W H Brooks; T L Roszman; D D Bigner; L Dudka; S Richardson
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

6.  Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours.

Authors:  W H Brooks; T L Roszman; M S Mahaley; R E Woosley
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

7.  Immunobiology of primary intracranial tumors. Part 5: Correlation of a lymphocyte index and clinical status.

Authors:  W H Brooks; R B Latta; M S Mahaley; T L Roszman; L Dudka; C Skaggs
Journal:  J Neurosurg       Date:  1981-03       Impact factor: 5.115

8.  Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours.

Authors:  T L Roszman; W H Brooks
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

9.  Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type.

Authors:  U Blom; H Blomgren; H Ullén; P Collins; H Von Holst
Journal:  Anticancer Res       Date:  1985 Jul-Aug       Impact factor: 2.480

10.  Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.

Authors:  W H Brooks; M G Netsky; D E Normansell; D A Horwitz
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Vaccine strategies for glioblastoma: progress and future directions.

Authors:  Christopher Jackson; Jacob Ruzevick; Henry Brem; Michael Lim
Journal:  Immunotherapy       Date:  2013-02       Impact factor: 4.196

2.  Immunohistochemical study of IOT-10 natural killer cells in brain metastases.

Authors:  J Vaquero; S Coca; J Escandón; R Magallón; R Martínez
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 3.  Vaccine therapies for patients with glioblastoma.

Authors:  Eli T Sayegh; Taemin Oh; Shayan Fakurnejad; Orin Bloch; Andrew T Parsa
Journal:  J Neurooncol       Date:  2014-08-28       Impact factor: 4.130

Review 4.  Next Steps for Immunotherapy in Glioblastoma.

Authors:  Toni Q Cao; Derek A Wainwright; Catalina Lee-Chang; Jason Miska; Adam M Sonabend; Amy B Heimberger; Rimas V Lukas
Journal:  Cancers (Basel)       Date:  2022-08-20       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.